Concepedia

Yasuhiro Egi

YE

Statistics

Publications

14

Citations

525

H-Index

13

Active since

1992

Affiliations

Osaka University of Pharmaceutical Sciences(Current)

Mitsubishi Tanabe Pharma Corporation

Harvard University

Massachusetts General Hospital

Mitsubishi Chemical (Japan)

Yasuhiro Egi is an author at Osaka University of Pharmaceutical Sciences specializing in medicine, pharmacology, and vascular biology.

Top concepts

Publications per year

1992–2018

14

Publications

14

Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma

Masahide Nakajima, Kazutaka Hayashi, Yasuhiro Egi et al. · Cancer Chemotherapy and Pharmacology · 2003 · 79 citations

, , +7

Edaravone, a free radical scavenger, protects components of the neurovascular unit against oxidative stress in vitro

Brian J. Lee, Yasuhiro Egi, Klaus van Leyen et al. · Brain Research · 2009 · 78 citations

, , +10

Wf-536 prevents tumor metastasis by inhibiting both tumor motility and angiogenic actions

Masahide Nakajima, Kazutaka Hayashi, Kenichi Katayama et al. · European Journal of Pharmacology · 2003 · 69 citations

, , +8

The effects of NG-nitro-L-arginine, a nitric oxide synthase inhibitor, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs.

Yasuhiro Egi, Yasuo Matsumura, S Murata et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 52 citations

MP-124, a novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor, ameliorates ischemic brain damage in a non-human primate model

Shigeru Matsuura, Yasuhiro Egi, Satoshi Yuki et al. · Brain Research · 2011 · 45 citations

, , +12

1–5 of 14